Luke W. Meredith

5.2k total citations
38 papers, 1.3k citations indexed

About

Luke W. Meredith is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Luke W. Meredith has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Infectious Diseases and 14 papers in Hepatology. Recurrent topics in Luke W. Meredith's work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Luke W. Meredith is often cited by papers focused on Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Luke W. Meredith collaborates with scholars based in United Kingdom, United States and France. Luke W. Meredith's co-authors include Jane A. McKeating, Nicola F. Fletcher, David Harrich, Peter Balfe, Garrick K. Wilson, Ian Goodfellow, Ke Hu, Thomas F. Baumert, Andreas Suhrbier and Jennifer M. Timpe and has published in prestigious journals such as Science, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Luke W. Meredith

37 papers receiving 1.3k citations

Peers

Luke W. Meredith

EPIDE

HEPAT

VIROL

Laura Solforosi Italy

Olga Kalinina Russia

Ivo C. Lorenz United States

Hans Heiken Germany

David J. Woollard Australia

Jorge Quarleri Argentina

Steve S.-L. Chen Taiwan

Cynthia Johnson United States

Wei Cun China

Cherie Ng United States

Laura Solforosi Italy

Luke W. Meredith

646 ×1.1

EPIDE

536 ×1.0

HEPAT

924 ×2.5

211 ×0.7

92 ×0.4

VIROL

Citations per year, relative to Luke W. Meredith Luke W. Meredith (= 1×) peers Laura Solforosi

Countries citing papers authored by Luke W. Meredith

Since Specialization

Citations

This map shows the geographic impact of Luke W. Meredith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke W. Meredith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke W. Meredith more than expected).

Fields of papers citing papers by Luke W. Meredith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke W. Meredith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke W. Meredith. The network helps show where Luke W. Meredith may publish in the future.

Co-authorship network of co-authors of Luke W. Meredith

This figure shows the co-authorship network connecting the top 25 collaborators of Luke W. Meredith. A scholar is included among the top collaborators of Luke W. Meredith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke W. Meredith. Luke W. Meredith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meredith, Luke W., et al.. (2024). Complication Rate of the Nuss Procedure in Adults and Pediatric Patients: National Database Analysis. SHILAP Revista de lepidopterología. 2(3). 364–368.

Dinan, Adam M., Shiho Torii, Hazel Stewart, et al.. (2024). Zika viruses encode 5′ upstream open reading frames affecting infection of human brain cells. Nature Communications. 15(1). 8822–8822. 2 indexed citations

Meredith, Luke W., et al.. (2024). Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion. Clinical Lung Cancer. 26(2). e99–e107.e10. 1 indexed citations

Shridas, Preetha, Ailing Ji, Victoria P. Noffsinger, et al.. (2024). Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation. Atherosclerosis. 391. 117492–117492. 1 indexed citations

Meredith, Luke W., et al.. (2024). Incidence and Management of Cardiothoracic Relevant Extrapulmonary Findings Found on Low-Dose Computed Tomography. The Annals of Thoracic Surgery. 118(2). 358–364. 1 indexed citations

Meredith, Luke W., et al.. (2023). Implementation and expansion of laboratory capacity for molecular diagnostics in response to COVID‐19 and preparedness for other emerging infectious diseases in the Islamic Emirate of Afghanistan. Influenza and Other Respiratory Viruses. 17(11). e13210–e13210. 2 indexed citations

Ji, Ailing, Victoria P. Noffsinger, Luke W. Meredith, et al.. (2023). Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice. International Journal of Molecular Sciences. 24(24). 17501–17501. 6 indexed citations

Meredith, Luke W., et al.. (2023). Monitoring the quality of SARS‐CoV‐2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID‐19 pandemic. Influenza and Other Respiratory Viruses. 17(11). e13217–e13217. 2 indexed citations

Meredith, Luke W., et al.. (2023). Time trend of respiratory viruses before and during the COVID‐19 pandemic in severe acute respiratory virus infection in the Sultanate of Oman between 2017 and 2022. Influenza and Other Respiratory Viruses. 17(12). e13233–e13233. 5 indexed citations

10.

Abu‐Dayyeh, Issa, et al.. (2023). A model for public–private partnership during the COVID‐19 pandemic: Lessons from Biolab and public laboratories working in the Hashemite Kingdom of Jordan. Influenza and Other Respiratory Viruses. 17(10). e13209–e13209. 4 indexed citations

11.

Yakovleva, Anna, Eric Bortz, Joel O. Wertheim, et al.. (2022). Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021. Scientific Reports. 12(1). 15749–15749. 20 indexed citations

12.

Subissi, Lorenzo, A Perrocheau, Joshua Quick, et al.. (2021). A large epidemic of a necrotic skin infection in the Democratic Republic of São Tomé and Principe: an epidemiological study. International Journal of Infectious Diseases. 110. S69–S76. 4 indexed citations

13.

Meredith, Luke W., Stanislav V. Sosnovtsev, Miranda de Graaf, et al.. (2021). A luciferase-based approach for measuring HBGA blockade antibody titers against human norovirus. Journal of Virological Methods. 297. 114196–114196. 5 indexed citations

14.

Ziv, Omer, Aaron T. L. Lun, Luca F. R. Gebert, et al.. (2018). COMRADES determines in vivo RNA structures and interactions. Nature Methods. 15(10). 785–788. 129 indexed citations

15.

Chavali, Pavithra L., Lovorka Stojic, Luke W. Meredith, et al.. (2017). Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science. 357(6346). 83–88. 117 indexed citations

16.

Fletcher, Nicola F., Rupesh Sutaria, Juandy Jo, et al.. (2013). Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology. 59(4). 1320–1330. 37 indexed citations

17.

Meredith, Luke W., Nicole Zitzmann, & Jane A. McKeating. (2013). Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission. Antiviral Research. 100(3). 636–639. 10 indexed citations

18.

Tarr, Alexander W., Pierre Lafaye, Luke W. Meredith, et al.. (2013). An Alpaca Nanobody Inhibits Hepatitis C Virus Entry And Cell-To-Cell Transmission. Hepatology. 58(3). 932–939. 60 indexed citations

19.

Meredith, Luke W., Haran Sivakumaran, Lee Major, Andreas Suhrbier, & David Harrich. (2009). Potent Inhibition of HIV-1 Replication by a Tat Mutant. PLoS ONE. 4(11). e7769–e7769. 51 indexed citations

20.

Harrich, David, Nigel A.J. McMillan, Liliana Endo‐Munoz, Ann Apolloni, & Luke W. Meredith. (2006). Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?. Current Drug Targets. 7(12). 1595–1606. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact